Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure

被引：0
|
作者：
Alexander Jetter
Martina Kinzig-Schippers
Michael Illauer
Robert Hermann
Katharina Erb
Jürgen Borlak
Helga Wolf
Gillian Smith
Ingolf Cascorbi
Fritz Sörgel
Uwe Fuhr
机构：
[1] University of Cologne,Department of Pharmacology, Clinical Pharmacology
[2] Institute for Biomedical and Pharmaceutical Research,Biomedical Research Centre
[3] ALTANA Pharma Deutschland GmbH,Institute of Pharmacology
[4] Clinphase–clinical pharmacology services,undefined
[5] ITEM Fraunhofer-Institut,undefined
[6] Ninewells Hospital and Medical School,undefined
[7] University of Greifswald,undefined
来源：
European Journal of Clinical Pharmacology | 2004年 / 60卷
关键词：
Caffeine; Arylamine; -acetyltransferase 2; Phenotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 21
页数：4
相关论文
共 50 条
  • [21] N-acetyltransferase 2 gene polymorphism and presbycusis
    Ünal, M
    Tamer, L
    Dogruner, ZN
    Yildirim, H
    Vayisoglu, Y
    Çamdeviren, H
    LARYNGOSCOPE, 2005, 115 (12): : 2238 - 2241
  • [22] N-acetyltransferase 2 activity and folate levels
    Cao, Wen
    Strnatka, Diana
    McQueen, Charlene A.
    Hunter, Robert J.
    Erickson, Robert P.
    LIFE SCIENCES, 2010, 86 (3-4) : 103 - 106
  • [23] Definite identification of N-acetyltransferase 2 genotype
    Agundez, J. A. G.
    Golka, K.
    Martinez, C.
    Selinski, S.
    Blaszkewicz, M.
    Garcia-Martin, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 62 - 62
  • [24] REDUCTION OF RAT PINEAL N-ACETYLTRANSFERASE ACTIVITY BY FETAL ALCOHOL EXPOSURE
    RUDEEN, PK
    KAPPEL, CA
    ALCOHOL AND ALCOHOLISM, 1986, 21 (02): : A48 - A48
  • [25] Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?
    Kinzig-Schippers, M
    Tomalik-Scharte, D
    Jetter, A
    Scheidel, B
    Jakob, V
    Rodamer, M
    Cascorbi, I
    Doroshyenko, O
    Sörgel, F
    Fuhr, U
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) : 1733 - 1738
  • [26] Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene
    Cornish, VA
    Pinter, K
    Boukouvala, S
    Johnson, N
    Labrousse, C
    Payton, M
    Priddle, H
    Smith, AJH
    Sim, E
    PHARMACOGENOMICS JOURNAL, 2003, 3 (03): : 169 - 177
  • [27] Catalytic mechanism of hamster arylamine N-acetyltransferase 2
    Wang, HQ
    Liu, L
    Hanna, PE
    Wagner, CR
    BIOCHEMISTRY, 2005, 44 (33) : 11295 - 11306
  • [28] Characterisation of a phosphinothricin N-acetyltransferase from Pseudomonas syringae
    Davies, Anna M.
    Tata, Renee
    Trentham, David R.
    Sutton, Brian J.
    Brown, Paul R.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2015, 71 : S227 - S227
  • [29] N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population
    Al-Shaqha, Waleed M.
    Alkharfy, Khalid M.
    Al-Daghri, Nasser M.
    Mohammed, Abdul Khader
    ANNALS OF SAUDI MEDICINE, 2015, 35 (03) : 214 - 221
  • [30] Reconstruction of n-acetyltransferase 2 haplotypes using PHASE
    Selinski, S.
    Blaszkewicz, M.
    Bolt, H. M.
    Golka, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 68 - 68
12345